| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 3.704 | 5.066 | 5.352 | 5.359 | 45.475 | 123.150 | 157.740 | 162.853 |
| Total Income - EUR | - | 0 | 3.704 | 5.066 | 5.352 | 5.359 | 45.475 | 123.150 | 157.740 | 171.267 |
| Total Expenses - EUR | - | 0 | 5.841 | 14.555 | 18.956 | 21.761 | 49.608 | 114.644 | 152.300 | 159.835 |
| Gross Profit/Loss - EUR | - | 0 | -2.137 | -9.490 | -13.604 | -16.402 | -4.133 | 8.506 | 5.440 | 11.432 |
| Net Profit/Loss - EUR | - | 0 | -2.174 | -9.541 | -13.657 | -16.455 | -4.588 | 7.275 | 3.863 | 9.507 |
| Employees | - | 0 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 |
Check the financial reports for the company - Oanapharm70 Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 484 | 22.426 | 17.162 | 12.309 | 8.179 | 38.856 | 29.431 | 24.817 |
| Current Assets | - | 45 | 3.604 | 4.713 | 5.540 | 7.411 | 33.470 | 50.904 | 67.098 | 72.932 |
| Inventories | - | 0 | 3.485 | 3.729 | 4.760 | 6.843 | 16.569 | 28.165 | 32.680 | 24.520 |
| Receivables | - | 0 | 0 | 972 | 682 | 515 | 16.820 | 21.930 | 33.760 | 40.264 |
| Cash | - | 45 | 119 | 11 | 98 | 54 | 81 | 809 | 658 | 8.149 |
| Shareholders Funds | - | 45 | -2.131 | -11.632 | -25.064 | -41.044 | -44.803 | -37.667 | -33.690 | -14.989 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 9.046 |
| Debts | - | 0 | 6.218 | 38.771 | 47.766 | 60.765 | 86.452 | 127.427 | 130.220 | 112.738 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Oanapharm70 Med S.r.l.